Fexapotide TFA
Product Specifications
Target
Apoptosis
Related Pathways
Apoptosis
Bioactivity
Fexapotide (NX-1207) TFA selectively induces apoptosis, leading to a reduction in prostate volume at the cellular level. Fexapotide is applicable for research into lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) .
Molecular Formula
C90H163N27O25S.xC2HF3O2
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP2-12045-0.025mg 0.025 mg
Mouse Monoclonal Azurocidin/CAP37/HBP Antibody (MM0099-7F31)
Sign In for Pricing
View Details 
A00737-2-APC 100 µg/Vial
Anti-OPRM1 Antibody Picoband®, APC Conjugate
Sign In for Pricing
View Details